Search

Your search keyword '"Jerris, Robert C."' showing total 192 results
Start Over Author "Jerris, Robert C."
192 results on '"Jerris, Robert C."'

1. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)

Author

Miller, J Michael, primary, Binnicker, Matthew J, additional, Campbell, Sheldon, additional, Carroll, Karen C, additional, Chapin, Kimberle C, additional, Gonzalez, Mark D, additional, Harrington, Amanda, additional, Jerris, Robert C, additional, Kehl, Sue C, additional, Leal, Sixto M, additional, Patel, Robin, additional, Pritt, Bobbi S, additional, Richter, Sandra S, additional, Robinson-Dunn, Barbara, additional, Snyder, James W, additional, Telford, Sam, additional, Theel, Elitza S, additional, Thomson, Richard B, additional, Weinstein, Melvin P, additional, and Yao, Joseph D, additional

Published
2024
Full Text
View/download PDF

2. Risk of Skin and Soft Tissue Infections among Children Found to be Staphylococcus aureus MRSA USA300 Carriers

Author

Immergluck, Lilly, Jain, Shabnam, Ray, Susan, Mayberry, Robert, Satola, Sarah, Parker, Trisha Chan, Yuan, Keming, Mohammed, Anaam, and Jerris, Robert C

Subjects
Staphylococcus aureus carriage, MRSA, children, skin and soft tissue infection
Abstract

The purpose of this study was to examine community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) carriage and infections and determine risk factors associated specifically with MRSA USA300. A case control study was conducted in a pediatric emergency department. Nasal and axillary swabs were collected, and participants were interviewed for risk factors. The primary outcome was the proportion of S. aureus carriers among those presenting with and without a skin and soft tissue infection (SSTI). S. aureus carriers were further categorized into MRSA USA300 carriers or non MRSA USA300 carriers. We found MRSA USA300 carriage rate was higher in children less than 2 years of age, those with an SSTI, children with recent antibiotic use, and those with a family history of SSTI. MRSA USA300 carriers were also more likely to have lower income compared to non MRSA USA300 carriers and no S. aureus carriers. Rates of PVL genes were higher in MRSA carriage isolates with an SSTI, compared to MRSA carriage isolates of patients without an SSTI with an association between MRSA USA300 carriage and presence of PVL in those diagnosed with an abscess.

Published
2017

4. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases : 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology

Author

Miller, J. Michael, Binnicker, Matthew J., Campbell, Sheldon, Carroll, Karen C., Chapin, Kimberle C., Gilligan, Peter H., Gonzalez, Mark D., Jerris, Robert C., Kehl, Sue C., Patel, Robin, Pritt, Bobbi S., Richter, Sandra S., Robinson-Dunn, Barbara, Schwartzman, Joseph D., Snyder, James W., Telford, Sam, Theel, Elitza S., Thomson, Richard B., Weinstein, Melvin P., and Yao, Joseph D.

Published
2018

12. Rotavirus Strain Trends in United States, 2009–2016: Results from the National Rotavirus Strain Surveillance System (NRSSS)

Author

Mijatovic-Rustempasic, Slavica, primary, Jaimes, Jose, additional, Perkins, Charity, additional, Ward, M. Leanne, additional, Esona, Mathew D., additional, Gautam, Rashi, additional, Lewis, Jamie, additional, Sturgeon, Michele, additional, Panjwani, Junaid, additional, Bloom, Gail A., additional, Miller, Steve, additional, Reisdorf, Erik, additional, Riley, Ann Marie, additional, Pence, Morgan A., additional, Dunn, James, additional, Selvarangan, Rangaraj, additional, Jerris, Robert C., additional, DeGroat, Dona, additional, Parashar, Umesh D., additional, Cortese, Margaret M., additional, and Bowen, Michael D., additional

Published
2022
Full Text
View/download PDF

14. Chlamydia

Author

Bandea, Claudiu I., primary, Jerris, Robert C., additional, and Black, Carolyn M., additional

Published
2016
Full Text
View/download PDF

18. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19

Author

Ravichandran, Supriya, primary, Tang, Juanjie, additional, Grubbs, Gabrielle, additional, Lee, Youri, additional, Pourhashemi, Sara, additional, Hussaini, Laila, additional, Lapp, Stacey A., additional, Jerris, Robert C., additional, Singh, Vidisha, additional, Chahroudi, Ann, additional, Anderson, Evan J., additional, Rostad, Christina A., additional, and Khurana, Surender, additional

Published
2021
Full Text
View/download PDF

22. Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs

Author

Kociolek, Larry K., primary, Muller, William J., additional, Yee, Rebecca, additional, Dien Bard, Jennifer, additional, Brown, Cameron A., additional, Revell, Paula A., additional, Wardell, Hanna, additional, Savage, Timothy J., additional, Jung, Sarah, additional, Dominguez, Samuel, additional, Parikh, Bijal A., additional, Jerris, Robert C., additional, Kehl, Sue C., additional, Campigotto, Aaron, additional, Bender, Jeffrey M., additional, Zheng, Xiaotian, additional, Muscat, Emily, additional, Linam, Matthew, additional, Abuogi, Lisa, additional, Smith, Christiana, additional, Graff, Kelly, additional, Hernandez-Leyva, Ariel, additional, Williams, David, additional, and Pollock, Nira R., additional

Published
2020
Full Text
View/download PDF

27. Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012‐2017

Author

Kao, Carol M., primary, Lai, Kristina, additional, McAteer, John M., additional, Elmontser, Mohnd, additional, Quincer, Elizabeth M., additional, Yee, Marianne E.M., additional, Tippet, Ashley, additional, Jerris, Robert C., additional, Lane, Peter A., additional, Anderson, Evan J., additional, Bakshi, Nitya, additional, and Yildirim, Inci, additional

Published
2020
Full Text
View/download PDF

29. Will the real agent of cat-scratch disease please stand up?

Author

Jerris, Robert C. and Regnery, Russell L.

Subjects
Cat-scratch disease -- Development and progression -- Diagnosis, Lymphatic diseases -- Diagnosis -- Development and progression, Biological sciences, Diagnosis, Development and progression
Abstract

HISTORICAL PERSPECTIVE Detailed presentation of the many meaningful contributions made by primary researchers, microbiologists, and primary care and specialized clinicians towards an understanding of cat-scratch disease is beyond the scope [...]

Published
1996

30. Impact of a Rapid Respiratory Panel Test on Patient Outcomes

Author

Rogers, Beverly B., Shankar, Prabhu, Jerris, Robert C., Kotzbauer, David, Anderson, Evan J., Watson, J. Renee, OBrien, Lauren A., Uwindatwa, Francine, McNamara, Kelly, and Bost, James E.

Subjects
Influenza -- Patient outcomes -- Comparative analysis, Health
Abstract

Context.--Evolution of polymerase chain reaction testing for infectious pathogens has occurred concurrent with a focus on value-based medicine. Objective.--To determine if implementation of the FilmArray rapid respiratory panel (BioFire Diagnostics, Salt Lake City, Utah) (hereafter RRP), with a shorter time to the test result and expanded panel, results in different outcomes for children admitted to the hospital with an acute respiratory tract illness. Design.--Patient outcomes were compared before implementation of the RRP (November 1, 2011, to January 31, 2012) versus after implementation of the RRP (November 1, 2012, to January 31, 2013). The study included inpatients 3 months or older with an acute respiratory tract illness, most admitted through the emergency department. Testing before RRP implementation used batched polymerase chain reaction analysis for respiratory syncytial virus and influenza A and B, with additional testing for parainfluenza 1 through 3 in approximately 11% of patients and for human metapneumovirus in less than 1% of patients. The RRP tested for respiratory syncytial virus, influenza A and B, parainfluenza 1 through 4, human metapneumovirus, adenovirus, rhinovirus/enterovirus, and coronavirus NL62. Results.--The pre-RRP group had 365 patients, and the post-RRP group had 771 patients. After RRP implementation, the mean time to the test result was shorter (383 minutes versus 1119 minutes, P < .001), and the percentage of patients with a result in the emergency department was greater (51.6% versus 13.4%, P < .001). There was no difference in whether antibiotics were prescribed, but the duration of antibiotic use was shorter after RRP implementation (P = .003) and was dependent on receiving test results within 4 hours. If the test result was positive, the inpatient length of stay (P = .03) and the time in isolation (P = .03) were decreased after RRP implementation compared with before RRP implementation. Conclusions.--The RRP decreases the duration of antibiotic use, the length of inpatient stay, and the time in isolation. (Arch Pathol Lab Med. 2015; 139:636-641; doi: 10.5858/arpa.2014-0257-0A), The Institute of Medicine1 has identified the need to develop a systems approach to health care delivery, to be a 'continuously learning healthcare system.' Having real-time access to knowledge provides [...]

Published
2015
Full Text
View/download PDF

32. Prospective Cohort Study of Next-Generation Sequencing as a Diagnostic Modality for Unexplained Encephalitis in Children

Author

Haston, Julia C, primary, Rostad, Christina A, additional, Jerris, Robert C, additional, Milla, Sarah S, additional, McCracken, Courtney, additional, Pratt, Catherine, additional, Wiley, Michael, additional, Prieto, Karla, additional, Palacios, Gustavo, additional, Shane, Andi L, additional, and McElroy, Anita K, additional

Published
2019
Full Text
View/download PDF

34. Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections

Author

Charlton, Carmen L., primary, Babady, Esther, additional, Ginocchio, Christine C., additional, Hatchette, Todd F., additional, Jerris, Robert C., additional, Li, Yan, additional, Loeffelholz, Mike, additional, McCarter, Yvette S., additional, Miller, Melissa B., additional, Novak-Weekley, Susan, additional, Schuetz, Audrey N., additional, Tang, Yi-Wei, additional, Widen, Ray, additional, and Drews, Steven J., additional

Published
2018
Full Text
View/download PDF

36. Prospective Cohort Study of Next-Generation Sequencing as a Diagnostic Modality for Unexplained Encephalitis in Children.

Author

Haston, Julia C, Rostad, Christina A, Jerris, Robert C, Milla, Sarah S, McCracken, Courtney, Pratt, Catherine, Wiley, Michael, Prieto, Karla, Palacios, Gustavo, Shane, Andi L, and McElroy, Anita K

Subjects
CEREBROSPINAL fluid examination, ENCEPHALITIS diagnosis, BACTERIA, CEREBROSPINAL fluid, ENCEPHALITIS, GLUCOSE, LONGITUDINAL method, SERODIAGNOSIS, VIRUSES, GENOMICS, LEUKOCYTE count, SEQUENCE analysis, ADOLESCENCE, CHILDREN
Abstract

Background Encephalitis is an inflammatory condition of the brain associated with long-term neurologic sequelae and even death in children. Although viruses are often implicated, an etiology is not identified in the majority of cases. Metagenomics-based next-generation sequencing (mNGS) is a high-throughput sequencing technique that can enhance the detection of novel or low-frequency pathogens. Methods Hospitalized immunocompetent children aged 6 months to 18 years with encephalitis of unidentified etiology were eligible for enrollment. Demographic, historical, and clinical information was obtained, and residual blood and cerebrospinal fluid (CSF) samples were subjected to mNGS. Pathogens were identified by querying the sequence data against the NCBI GenBank database. Results Twenty children were enrolled prospectively between 2013 and 2017. mNGS of CSF identified 7 nonhuman nucleic acid sequences of significant frequency in 6 patients, including that of Mycoplasma bovis , parvovirus B19, Neisseria meningitidis , and Balamuthia mandrillaris. mNGS also detected Cladophialophora species, tobacco mosaic virus, and human bocavirus, which were presumed to be contaminants or nonpathogenic organisms. One patient was found to have positive serology results for California encephalitis virus, but mNGS did not detect it. Patients for whom mNGS identified a diagnosis had a significantly higher CSF white blood cell count, a higher CSF protein concentration, and a lower CSF glucose level than patients for whom mNGS did not identify a diagnosis. Conclusion We describe here the results of a prospective cohort analysis to evaluate mNGS as a diagnostic tool for children with unexplained encephalitis. Although mNGS detected multiple nonpathogenic organisms, it also identified multiple pathogens successfully and was most useful in patients with a CSF abnormality. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

38. Multicenter Evaluation of the ePlex Respiratory Pathogen Panel for the Detection of Viral and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs

Author

Babady, N. Esther, primary, England, Matthew R., additional, Jurcic Smith, Kristen L., additional, He, Taojun, additional, Wijetunge, Dona Saumya, additional, Tang, Yi-Wei, additional, Chamberland, Robin R., additional, Menegus, Marilyn, additional, Swierkosz, Ella M., additional, Jerris, Robert C., additional, and Greene, Wallace, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results